Salivary beta 2-microglobulin in NZB/WF1 mice

Area of Science:

• Immunology
• Biochemistry
• Oral Biology

Background:

• Sjögren's syndrome is an autoimmune disorder affecting salivary glands.
• Biomarkers for early detection and disease progression are needed.
• Murine models are crucial for understanding human autoimmune diseases.

Purpose of the Study:

• To investigate salivary beta 2-microglobulin (beta 2-MG) levels in NZB/WF1 mice.
• To analyze salivary protein composition changes in relation to age and disease.
• To assess the relevance of NZB/WF1 mice as a model for Sjögren's syndrome.

Main Methods:

• Collection of unstimulated parotid and submandibular/sublingual saliva from mice.
• Quantification of beta 2-MG using sandwich enzyme immunoassay.
• Fractionation of saliva by micro two-dimensional gel electrophoresis.

Main Results:

• Elevated salivary beta 2-MG in 45-week-old NZB/WF1 mice compared to controls.
• No significant increase in beta 2-MG at younger ages (5 and 20 weeks).
• Qualitative and quantitative protein composition changes in saliva of aged NZB/WF1 mice.

Conclusions:

• NZB/WF1 mice exhibit elevated salivary beta 2-MG with age.
• These salivary changes parallel those observed in human Sjögren's syndrome patients.
• NZB/WF1 mice represent a valuable model for studying Sjögren's syndrome pathogenesis.